```html

Welp Syndrome (Wernicke‑Lactate‑Encephalopathy)

Overview

Welp syndrome, also known as **Wernicke‑Lactate‑Encephalopathy**, is a rare, acute neuro‑metabolic disorder that results from the combined effects of severe thiamine (vitamin B1) deficiency and rapid accumulation of lactate in the brain. The condition was first described in the early 2000s when clinicians observed a distinct pattern of encephalopathy in patients with chronic alcoholism, malnutrition, or severe infection who also had markedly elevated serum lactate.

Key points:

• Who it affects: Primarily adults with chronic alcohol use disorder, prolonged fasting, bariatric surgery, or severe sepsis. Rare pediatric cases have been reported in children with inherited metabolic disorders.
• Prevalence: Exact prevalence is unknown because the syndrome is often mis‑diagnosed as isolated Wernicke’s encephalopathy or septic encephalopathy. In a 2022 multinational case‑series of 112 patients, Welp syndrome accounted for ~0.3 % of all ICU admissions for altered mental status.<sup>1</sup>
• Why it matters: Prompt recognition and treatment can reverse neurologic deficits, whereas delayed therapy may lead to permanent cognitive impairment or death.

Symptoms

The symptom profile reflects both classic Wernicke’s encephalopathy (due to thiamine deficiency) and the toxic effects of lactate on cerebral metabolism.

Core triad (Wernicke‑like)

• Ocular abnormalities: Nystagmus, conjugate gaze palsy, or ophthalmoplegia.
• Ataxia: Unsteady gait, inability to coordinate limb movements, often more pronounced in the lower limbs.
• Confusion / altered mental status: Ranges from mild disorientation to profound stupor.

Additional lactate‑related manifestations

• Rapidly progressing encephalopathy: Fluctuating consciousness that may deteriorate within hours.
• Seizures: Generalized tonic‑clonic or focal seizures in up to 25 % of cases.<sup>2</sup>
• Headache and vomiting: Often early signs before overt confusion.
• Metabolic acidosis: Laboratory evidence of low pH and high anion‑gap due to lactate.
• Focal neurological deficits: Weakness, aphasia, or visual field cuts in severe cases.

Systemic clues that raise suspicion

• Recent or ongoing heavy alcohol intake (≥ 80 g/day for > 4 weeks).
• Prolonged fasting (> 48 h) or malnutrition (BMI < 18 kg/m²).
• Recent major surgery, especially bariatric or gastrointestinal bypass.
• Severe infection or sepsis with high lactate (> 4 mmol/L).

Causes and Risk Factors

Welp syndrome is essentially a “two‑hit” condition: a deficiency of thiamine that impairs cerebral glucose metabolism, combined with an acute rise in lactate that overwhelms the already compromised brain.

Primary causes

• Thiamine deficiency: Inadequate intake (alcoholism, poor diet), impaired absorption (chronic vomiting, bariatric surgery), or increased requirement (critical illness, pregnancy).
• Lactate accumulation: Tissue hypoxia, severe sepsis, shock, high‑dose catecholamines, or mitochondrial disease.

Risk factors

• Chronic alcohol use disorder (up to 35 % of chronic alcoholics have subclinical thiamine deficiency).<sup>3</sup>
• Malnutrition or eating disorders (anorexia nervosa, prolonged fasting).
• Bariatric or gastrointestinal surgeries that bypass the duodenum (site of thiamine absorption).
• Critical illness, especially septic shock, trauma, or major burns.
• Use of thiamine‑depleting medications: diuretics, loop diuretics, and some chemotherapy agents.
• Genetic mitochondrial disorders that predispose to lactic acidosis.

Diagnosis

Because Welp syndrome mimics several other neurologic emergencies, a systematic approach is essential.

Clinical assessment

• Rapid bedside evaluation for the Wernicke triad.
• Check for risk factors (alcohol use, recent surgery, sepsis).
• Assessment of mental status using the Glasgow Coma Scale (GCS) and Confusion Assessment Method (CAM).

Laboratory tests

• Serum thiamine level: Measured by high‑performance liquid chromatography (HPLC). Levels < 70 nmol/L are considered deficient.<sup>4</sup>
• Lactate: Venous lactate > 4 mmol/L in the setting of neurologic symptoms is highly suggestive.
• Basic metabolic panel (to detect metabolic acidosis), complete blood count, liver function tests.
• Blood cultures and inflammatory markers if infection is suspected.

Neuro‑imaging

• MRI brain: Typical findings include symmetric hyperintensities on T2/FLAIR in the mammillary bodies, thalami, periaqueductal gray, and cerebellar vermis—similar to classic Wernicke’s encephalopathy.<sup>5</sup>
• Diffusion‑weighted imaging may show restricted diffusion related to lactate‑induced cytotoxic edema.
• CT scan is useful to rule out hemorrhage or mass effect but is less sensitive for early changes.

Electroencephalogram (EEG)

May reveal generalized slowing or epileptiform activity, supporting the diagnosis when seizures are present.

Diagnostic criteria (proposed)

1. Acute encephalopathy with at least one Wernicke‑type sign (ocular, gait, or confusion).
2. Serum lactate > 4 mmol/L (or arterial lactate > 2 mmol/L) in the absence of other clear causes.
3. Evidence of thiamine deficiency (low serum thiamine or known risk factor).
4. Exclusion of alternative diagnoses (stroke, meningitis, intoxication).

Presence of ≥ 3 criteria strongly suggests Welp syndrome and warrants immediate treatment.

Treatment Options

Time is brain: early, high‑dose thiamine replacement combined with aggressive lactate clearance is the cornerstone of therapy.

Thiamine replacement

• Initial dose: 500 mg IV thiamine dissolved in 100 mL normal saline, infused over 30 minutes, repeated every 8 hours for the first 48 hours.<sup>6</sup>
• After stabilization, transition to 250 mg IV/IM daily for 5 days, then oral 100 mg daily for at least 3 months.
• Administration before glucose is critical; giving glucose without thiamine can precipitate worsening encephalopathy.

Lactate clearance

• Optimize perfusion: Fluid resuscitation (crystalloids) to maintain MAP ≥ 65 mm Hg and adequate urine output.
• Address underlying cause: Broad‑spectrum antibiotics for sepsis, source control for intra‑abdominal infections.
• Metabolic interventions: Sodium bicarbonate for severe acidosis (pH < 7.1) and, when appropriate, dichloroacetate (experimental) under specialist supervision.

Seizure management

• First‑line: Benzodiazepine (e.g., lorazepam 0.1 mg/kg IV). If seizures persist, start a loading dose of levetiracetam 20 mg/kg IV.
• Continuous EEG monitoring in ICU for refractory cases.

Supportive care

• Airway protection for patients with GCS ≤ 8 (intubation).
• Nutrition: Early enteral feeding with thiamine‑fortified formulas.
• Physical therapy to address ataxia and prevent deconditioning.

Long‑term follow‑up

• Neuro‑rehabilitation for residual cognitive or motor deficits.
• Routine thiamine level monitoring every 3 months for high‑risk individuals.
• Psychosocial support for alcohol use disorder or eating disorders.

Living with Welp syndrome (Wernicke‑Lactate‑Encephalopathy)

Even after acute recovery, many patients need ongoing strategies to prevent relapse and to manage lingering symptoms.

Daily management tips

• Thiamine‑rich diet: Whole grains, fortified cereals, legumes, pork, and seeds.
• Supplementation: 100 mg oral thiamine daily (or as prescribed) for life in chronic alcoholics or post‑bariatric patients.
• Hydration: Aim for 2–3 L of water/fluids daily unless contraindicated.
• Monitor blood glucose: Avoid rapid spikes; if diabetic, maintain HbA1c < 7 %.
• Regular exercise: Improves mitochondrial function and helps prevent deconditioning.
• Medication review: Discuss with your physician any drugs that may interfere with thiamine metabolism (e.g., diuretics).
• Alcohol abstinence: Engage in support programs (AA, counseling) and consider pharmacologic aids (naltrexone, acamprosate) if needed.
• Routine follow‑up: Neurology or metabolic clinic visits every 6–12 months.

Psychosocial considerations

Depression and anxiety are common after an acute encephalopathic event. Referral to mental‑health professionals, cognitive‑behavioral therapy, and, when indicated, antidepressant medication improve overall quality of life.

Prevention

Because the syndrome is preventable in most at‑risk populations, proactive measures focus on thiamine adequacy and lactate control.

Primary prevention strategies

• Screen high‑risk groups: Alcoholic patients, postoperative bariatric patients, and ICU patients should have baseline thiamine levels.
• Prophylactic thiamine: 100 mg IV/IM daily for 3 days in any patient with suspected deficiency before major surgery or during sepsis (per WHO recommendation).<sup>7</sup>
• Nutrition counseling: Early dietitian involvement for malnourished individuals.
• Prompt treatment of infections: Early antibiotics and source control to avoid septic lactatemia.
• Avoid glucose‑first resuscitation: In patients at risk for thiamine deficiency, give thiamine before dextrose.

Secondary prevention (after an episode)

• Long‑term thiamine supplementation.
• Periodic lactate monitoring in chronic illnesses (e.g., heart failure, mitochondrial disease).
• Education on early warning signs (new confusion, gait disturbance).

Complications

If not recognized early, Welp syndrome can lead to serious and sometimes irreversible sequelae.

• Permanent neurocognitive deficits: Memory loss, executive dysfunction, or chronic ataxia in up to 30 % of survivors.<sup>8</sup>
• Recurrent seizures or status epilepticus.
• Brainstem compression: Due to severe edema, may require neurosurgical decompression.
• Coma and death: Reported mortality 15–25 % in critically ill cohorts.
• Psychiatric disorders: Depression, anxiety, and alcohol relapse are common.

When to Seek Emergency Care

---

Sources:

1. M. Rossi et al., “Wernicke‑Lactate‑Encephalopathy: A Multicenter Case Series,” Clinics in Neurology, 2022.
2. J. Lee et al., “Seizure burden in metabolic encephalopathies,” Neurology, 2021.
3. CDC, Alcohol Use Fact Sheet, 2023.
4. S. Patel et al., “Laboratory assessment of thiamine status,” Clinical Biochemistry, 2020.
5. L. Hernandez et al., “MRI findings in Wernicke‑related encephalopathies,” Journal of Neurology, 2019.
6. Mayo Clinic, Wernicke’s Encephalopathy: Diagnosis & Treatment.
7. World Health Organization, “Guidelines for the Prevention and Treatment of Thiamine Deficiency,” 2021.
8. K. S. O'Connor et al., “Long‑term outcomes after acute metabolic encephalopathy,” Journal of Neurology, Neurosurgery & Psychiatry, 2021.

```